Great Point Partners, a Greenwich-based private investment firm focused exclusively on the health care industry, announced today the acquisition of a majority stake in Eutecma (or “the Company”), a German-based developer of sustainable, modular, and reusable temperature-controlled packaging solutions for pharmaceutical cold chain shipments.
Since its founding in 2008, Eutecma has been committed to producing passive cooling systems that make transport and logistics more sustainable and efficient. Eutecma is a leader in the pharmaceutical industry with its patented ICECATCH® cooling systems being a top choice among pharmaceutical, medical, and laboratory diagnostics businesses.
Eutecma’s “retecma” has created a circular system for its packaging materials with an extensive network of Refreshment Centers. The process ensures materials remain in circulation for as long as possible while shrinking carbon dioxide (CO2) emissions, and provides real-time CO2 reduction data to clients.
“We have successfully created innovative and sustainable cold chain solutions that have proven themselves with well-known pharmaceutical customers,” said Eutecma Co-Founder, Florian Zeilfelder. “Our work with GPP will advance that mission so we can strategically expand our reach, especially in the US and other geographies around the world.”
“Florian and I took a leap of faith when founding Eutecma because we knew we had an innovative idea for our industry,” said Eutecma Co-Founder, Markus Baumgärtner. “Nearly 17 years later we have the chance to make even greater strides, and we’re thrilled to have GPP’s support in this next phase of growth.”
With this partnership, Eutecma has also acquired Resolvision, Eutecma’s proprietary re-use machine technology utilized at its Refreshment Centers.
“Eutecma impressed us with their innovative technology and approach to sustainability that is making a significant impact for pharmaceutical clients,” said Eddie Hjerpe, Senior Vice President at GPP. “Their temperature performance, CO2 reduction data, and differentiated engineering is exactly what the evolving cold-chain industry is looking for today.”
“Eutecma has the opportunity to further expand its global capabilities at a time when there’s growing demand for reusability, cost-savings, and new cooling technologies within cold chain,” said Harrison Johnson, Vice President at GPP. “This investment underscores our dedication to supporting exceptional high growth healthcare companies that assist in bringing lifesaving medicines to patients across the globe.”
Discover the latest trends and insights—explore the Business Insights Journal for up-to-date strategies and industry breakthroughs!
